In agreement with the in vitro findings, the expression of NRAS, p-ERK1/2, CDK4, Cdc25A, and CydlinD1 was inhibited in tumor grafts with the treatment of DHA (Fig. 5I–J). This evidence concerns the gene MAPK3 and neoplasm.